Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 83
Number of items: 83
  • Terranova, R., Yokobayashi, S., Stadler, M. B., Otte, A. P., van Lohuizen, M., Orkin, S. H., & Peters, A. H. F. M. (2008). Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Developmental Cell, 15(5), 668-679. https://doi.org/10.1016/j.devcel.2008.08.015
  • Endoh, M., Endo, T. A., Endoh, T., Fujimura, Y., Ohara, O., Toyoda, T., Otte, A. P., Okano, M., Brockdorff, N., Vidal, M., & Koseki, H. (2008). Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity. Development - The Company of Biologists, 135(8), 1513-1524. https://doi.org/10.1242/dev.014340
  • Open Access
    Vékony, H., Raaphorst, F. M., Otte, A. P., van Lohuizen, M., Leemans, C. R., van der Waal, I., & Bloemena, E. (2008). High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. Journal of clinical pathology, 61(6), 744-749. https://doi.org/10.1136/jcp.2007.054262
  • Open Access
    Kwaks, T. H. J. (2008). Employing epigenetics to augment protein expression in mammalian cells. [Thesis, fully internal, Universiteit van Amsterdam].
  • Hoffmann, M. J., Engers, R., Florl, A. R., Otte, A. P., Müller, M., & Schulz, W. A. (2007). Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer. Cancer Biology & Therapy, 6(9), 1403-1412. https://doi.org/10.4161/cbt.6.9.4542
  • van Galen, J. C., Muris, J. J., Oudejans, J. J., Vos, W., Giroth, C. P., Ossenkoppele, G. J., Otte, A. P., Raaphorst, F. M., & Meijer, C. J. (2007). Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL. Journal of clinical pathology, 60(2), 167-172. https://doi.org/10.1136/jcp.2006.038752
  • van Blokland, H. J. M., Kwaks, T. H. J., Sewalt, R. G. A. B., Verhees, J. A., Klaren, V. N. A., Siersma, T. K., Korse, J. W. M., Teunissen, N. C., Botschuijver, S., van Mer, C., Man, S. Y., & Otte, A. P. (2007). A novel, high stringency selection system allows screening of few clones for high protein expression. Journal of Biotechnology, 128(2), 237-245. https://doi.org/10.1016/j.jbiotec.2006.09.023
  • van Leenders, G. J., Dukers, D., Hessels, D., van den Kieboom, S. W., Hulsbergen, C. A., Witjes, J. A., Otte, A. P., Meijer, C. J., & Raaphorst, F. M. (2007). Polycomb-Group Oncogenes EZH2, BMI1, and RING1 are overexpressed in Prostate Cancer with adverse pathologic and clinial features. European Urology, 52(2), 455-463. https://doi.org/10.1016/j.eururo.2006.11.020
  • Otte, A. P., Kwaks, T. H. J., van Blokland, R. J., Sewalt, R. G. A. B., Verhees, J. A., Klaren, V. N. A., Siersma, T. K., Korse, H. W., Teunissen, N. C., Botschuijver, S., van Mer, C., & Man, S. Y. (2007). Various expression-augmenting DNA elements benefit from STAR-Select, a novel high stringency selection system for protein expression. Biotechnology progress, 23(4), 801-807. https://doi.org/10.1021/bp070107r
  • Kwaks, T. H. J., & Otte, A. P. (2006). Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends in Biotechnology, 24(3), 137-142. https://doi.org/10.1016/j.tibtech.2006.01.007
Page 2 of 9